Detailed Summary
Overview of the current peptide trend and the critical lack of human evidence for many compounds. The goal is to separate marketing claims from clinical data across four main categories: regenerative, neurological, growth hormone, and aesthetic peptides.
Joint and Regenerative Peptides (01:15 - 09:44)
- Thymosin Beta 4 (TB4): Naturally occurring in platelets and the thymus. While animal studies show 60% faster wound healing, human data is limited to eye health, where it helps with dry eye and corneal wounds. It is proven safe in humans at various doses.
- Thymosin Alpha 1: A potent immune modulator approved in 35 countries. It enhances T-cell output and vaccine response in the elderly, though it does not structurally regrow the thymus.
- BPC-157: Derived from stomach protein, it is highly popular for tendon and ligament repair. However, there are zero completed human clinical trials; all evidence is based on rodents or anecdotes.
Brain and Mitochondrial Peptides (10:43 - 24:30)
- Epitalon: A Russian bioregulator that may modulate the circadian clock and extend telomeres. Observational studies suggest significant reductions in mortality and heart disease, though these are limited by potential conflicts of interest.
- MOTS-c: A mitochondrial peptide that acts as an "exercise mimetic." It improves insulin sensitivity in mice. In humans, exercise naturally spikes MOTS-c levels 11.9-fold in muscle.
- Humanin: Associated with cognitive health and lower Alzheimer's risk. It increases autophagy and lowers IGF-1, but lacks human intervention trials.
- Cerebrolysin: A mix of brain growth factors used for 30 years. Clinical trials confirm it aids short-term recovery from stroke and traumatic brain injury, though it doesn't reduce long-term mortality.
- Semax: A Russian neotropic used for stroke and neuropathy; it upregulates BDNF and neurotransmitters but lacks high-quality Western trials.
Growth Hormone Secretagogues (24:30 - 29:25)
- CJC-1295: Increases growth hormone 2-10 fold and IGF-1 up to 3-fold. While effective for body composition, a phase 2 trial was terminated following a subject's death (though deemed unrelated).
- MK-677 (Ibutamoren): An oral ghrelin mimetic that increases lean mass in the elderly and boosts REM sleep by 50%. It causes significant hunger and water retention.
- Tesamorelin: FDA-approved for reducing visceral fat in HIV patients. It is highly effective for fat loss while preserving muscle mass.
- IGF-1 LR3: A synthetic version of IGF-1 with no human clinical trials, despite animal data showing growth-promoting effects.
Aesthetic and Weight Loss Peptides (29:45 - 35:30)
- Copper GHK-Cu: Naturally declines with age. Topical application is proven to increase skin thickness, reduce wrinkles by over 50%, and stimulate hair follicles.
- Retatrutide: A triple GLP-1 agonist showing unprecedented weight loss (up to 24-30%), surpassing Ozempic and Mounjaro in clinical trials.
- Melanotan 2: Increases skin pigmentation and libido. It may suppress appetite via melanocortin receptors but carries risks of darkening moles or melanoma.
Final ranking and safety warnings regarding the peptide landscape.
- A summary table confirms that BPC-157, MOTS-c, and Humanin have zero human studies.
- Emphasis on the "gray area" of sourcing; random online purchases are often contaminated or fake.
- Recommendation to only use compounding pharmacies and work under medical supervision.
